For example, several clinical trials have shown no significant changes in the serum ALB concentration, MELD score, or serum aminotransferase level in patients with hepatic fibrosis who underwent autologous bone marrow MSCs transplantation at the 12-month follow-up (Yang et al., 2020a). Here, ALB is linked to Hepatic fibrosis.